$10.02
0.212.14%
At Close: -
$10.02
00.00%
After Hours: Jul 5, 4:00 PM EDT
15 minutes delayed
Amicus Therapeutics
FOLDNASDAQ
Amicus Therapeutics (NASDAQ:FOLD) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | FOLD | Amicus Therapeutics | FY | 2024 | — | — | — | $499.19M | $519.16M | $529.99M | Get Alert |
| 01/07/2024 | FOLD | Amicus Therapeutics | FY | 2023 | — | — | — | $399.40M | $399.40M | $396.45M | Get Alert |
| 01/09/2023 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $329.00M | $329.00M | $326.68M | Get Alert |
| 08/04/2022 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $350.00M | $365.00M | $355.01M | Get Alert |
| 05/09/2022 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $350.00M | $365.00M | $363.85M | Get Alert |
| 02/24/2022 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $350.00M | $365.00M | $375.35M | Get Alert |
| 01/10/2022 | FOLD | Amicus Therapeutics | Q4 | 2021 | — | — | — | $84.00M | $84.00M | $84.77M | Get Alert |
| 01/10/2022 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $350.00M | $365.00M | $396.55M | Get Alert |
| 01/10/2022 | FOLD | Amicus Therapeutics | FY | 2021 | — | — | — | $306.00M | $306.00M | $308.46M | Get Alert |
| 11/09/2021 | FOLD | Amicus Therapeutics | FY | 2021 | — | — | — | $300.00M | $315.00M | $310.30M | Get Alert |
| 08/05/2021 | FOLD | Amicus Therapeutics | FY | 2021 | — | — | — | $300.00M | $315.00M | $308.54M | Get Alert |
| 05/10/2021 | FOLD | Amicus Therapeutics | FY | 2021 | — | — | — | $300.00M | $315.00M | $312.64M | Get Alert |
| 01/11/2021 | FOLD | Amicus Therapeutics | FY | 2021 | — | — | — | $300.00M | — | $335.44M | Get Alert |
| 01/11/2021 | FOLD | Amicus Therapeutics | Q4 | 2020 | — | — | — | $70.00M | $70.00M | $69.53M | Get Alert |
| 01/11/2021 | FOLD | Amicus Therapeutics | FY | 2020 | — | — | — | $261.00M | $261.00M | $259.24M | Get Alert |
| 11/05/2020 | FOLD | Amicus Therapeutics | FY | 2020 | — | — | — | $250.00M | $260.00M | $256.88M | Get Alert |
| 08/10/2020 | FOLD | Amicus Therapeutics | FY | 2020 | — | — | — | $250.00M | $260.00M | $254.82M | Get Alert |
| 07/17/2020 | FOLD | Amicus Therapeutics | FY | 2020 | — | — | — | $250.00M | $260.00M | $255.22M | Get Alert |
| 05/07/2020 | FOLD | Amicus Therapeutics | FY | 2020 | — | — | — | $250.00M | $260.00M | $257.09M | Get Alert |
| 03/02/2020 | FOLD | Amicus Therapeutics | FY | 2020 | — | — | — | $250.00M | $260.00M | $256.47M | Get Alert |
| 01/13/2020 | FOLD | Amicus Therapeutics | FY | 2020 | — | — | — | $250.00M | $260.00M | $256.70M | Get Alert |
| 01/13/2020 | FOLD | Amicus Therapeutics | FY | 2019 | — | — | — | $181.00M | $181.00M | $178.23M | Get Alert |
| 11/11/2019 | FOLD | Amicus Therapeutics | FY | 2019 | — | — | — | $170.00M | $180.00M | $177.33M | Get Alert |
| 10/10/2019 | FOLD | Amicus Therapeutics | Q3 | 2019 | — | — | — | $48.00M | $48.00M | $45.43M | Get Alert |
| 10/10/2019 | FOLD | Amicus Therapeutics | FY | 2019 | — | — | — | $170.00M | $180.00M | $175.42M | Get Alert |
FAQ
What is the most recent guidance for Amicus Therapeutics (FOLD)?
There have been no specific sales or earnings guidance reported for Amicus Therapeutics in recent months.
Browse guidance and forecast on all stocks.